# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Venus Concept (NASDAQ:VERO) reported quarterly losses of $(3.05) per share which missed the analyst consensus estimate of $(1.4...
https://health-products.canada.ca/mdall-limh/information?licenceId=111568&type=active&lang=eng